Innovative CAR-T cells effectively target glioblastoma with reduced toxicity

  • Post author:
  • Post category:uncategorized

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.